Orly Marcu

1.1k total citations
8 papers, 144 citations indexed

About

Orly Marcu is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Orly Marcu has authored 8 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Orly Marcu's work include Protein Structure and Dynamics (2 papers), Peptidase Inhibition and Analysis (2 papers) and Computational Drug Discovery Methods (2 papers). Orly Marcu is often cited by papers focused on Protein Structure and Dynamics (2 papers), Peptidase Inhibition and Analysis (2 papers) and Computational Drug Discovery Methods (2 papers). Orly Marcu collaborates with scholars based in Israel, United States and Singapore. Orly Marcu's co-authors include Ora Schueler‐Furman, Sergey Lyskov, Dima Kozakov, Nawsad Alam, Marc F. Lensink, Dana G. Wolf, Assaf Friedler, Moshe Kotler, Yiska Weisblum and Avraham Shaag and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Scientific Reports.

In The Last Decade

Orly Marcu

8 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orly Marcu Israel 5 115 25 21 21 17 8 144
Joanne Kotz United States 6 88 0.8× 33 1.3× 16 0.8× 20 1.0× 11 0.6× 25 160
Hunter Nisonoff United States 7 205 1.8× 22 0.9× 19 0.9× 16 0.8× 23 1.4× 9 252
Victor Reys France 5 115 1.0× 17 0.7× 12 0.6× 12 0.6× 11 0.6× 10 171
Mireia Rosell Spain 6 122 1.1× 44 1.8× 11 0.5× 24 1.1× 6 0.4× 8 149
Sonja B. Lauterbach South Africa 7 61 0.5× 23 0.9× 25 1.2× 10 0.5× 18 1.1× 8 169
Mikhail Ignatov United States 9 162 1.4× 38 1.5× 32 1.5× 23 1.1× 13 0.8× 12 192
Lynn DeLeeuw United States 10 269 2.3× 17 0.7× 44 2.1× 14 0.7× 36 2.1× 15 349
Manjuan Liu United Kingdom 6 120 1.0× 18 0.7× 25 1.2× 6 0.3× 10 0.6× 8 148
Adam Moyer United States 6 126 1.1× 10 0.4× 18 0.9× 25 1.2× 6 0.4× 10 172
James E. Lucas United States 6 304 2.6× 36 1.4× 12 0.6× 35 1.7× 15 0.9× 8 349

Countries citing papers authored by Orly Marcu

Since Specialization
Citations

This map shows the geographic impact of Orly Marcu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orly Marcu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orly Marcu more than expected).

Fields of papers citing papers by Orly Marcu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orly Marcu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orly Marcu. The network helps show where Orly Marcu may publish in the future.

Co-authorship network of co-authors of Orly Marcu

This figure shows the co-authorship network connecting the top 25 collaborators of Orly Marcu. A scholar is included among the top collaborators of Orly Marcu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orly Marcu. Orly Marcu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gaur, Pratibha, Orly Marcu, Ora Schueler‐Furman, et al.. (2023). 2B4: A potential target in Staphylococcus aureus associated allergic inflammation. Clinical & Experimental Immunology. 215(1). 37–46. 2 indexed citations
2.
Mayer, Guy, et al.. (2020). Targeting an Interaction Between Two Disordered Domains by Using a Designed Peptide. Chemistry - A European Journal. 26(45). 10156–10156. 1 indexed citations
3.
Weintraub, Michael, Orly Marcu, Polina Stepensky, et al.. (2020). A mutation in POLR3E impairs antiviral immune response and RNA polymerase III. Proceedings of the National Academy of Sciences. 117(36). 22113–22121. 19 indexed citations
4.
Mayer, Guy, et al.. (2020). Targeting an Interaction Between Two Disordered Domains by Using a Designed Peptide. Chemistry - A European Journal. 26(45). 10240–10249. 3 indexed citations
5.
Khramushin, Alisa, Orly Marcu, Nawsad Alam, et al.. (2019). Modeling beta‐sheet peptide‐protein interactions: Rosetta FlexPepDock in CAPRI rounds 38‐45. Proteins Structure Function and Bioinformatics. 88(8). 1037–1049. 12 indexed citations
6.
Marcu, Orly, Yu Zhang, Teck Kwang Lim, et al.. (2018). Yeast aconitase mitochondrial import is modulated by interactions of its C and N terminal domains and Ssa1/2 (Hsp70). Scientific Reports. 8(1). 5903–5903. 10 indexed citations
7.
Marcu, Orly, et al.. (2016). Peptiderive server: derive peptide inhibitors from protein–protein interactions. Nucleic Acids Research. 44(W1). W536–W541. 77 indexed citations
8.
Marcu, Orly, et al.. (2016). FlexPepDock lessons from CAPRI peptide–protein rounds and suggested new criteria for assessment of model quality and utility. Proteins Structure Function and Bioinformatics. 85(3). 445–462. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026